INTRODUCTION 40
Although antiretroviral therapy (ART) can lower the level of plasma viremia in HIV-41 infected individuals to below the limit of detection (<50 copies/ml) (12), it does not eradicate the 42 virus. In this regard, it has been demonstrated that a pool of latently infected CD4 + T cells 43 persists in virtually all infected individuals receiving ART for prolonged durations, and the 44 existence of such infected cells has been suggested as one of the major obstacles to achieving 45 eradication of the virus (4, 5, 13) . Therefore, understanding the mechanisms contributing to the 46 maintenance of HIV latency is essential for the development of therapeutic strategies aimed at 47 eradicating the virus in infected individuals receiving ART. 48
CpG methylation, an epigenetic transcriptional silencing mechanism critical for 49 organismal development and cell differentiation, has been implicated in suppressing the 50 expression of various endogenous and/or infectious retroviruses, such as human T-cell leukemia 51 virus type-1 (8), Moloney murine leukemia virus (11), Rous sarcoma virus (6), and human 52 endogenous retroviruses of the H, K, and W families (9, 10). Recently, CpG methylation has 53 been proposed as an important restriction factor contributing to the maintenance and stability of 54 HIV latency (1, 7). It has been suggested that the degree of methylation in the promoter/enhancer 55 region, 5' long terminal repeat (LTR), of HIV DNA negatively correlates with the level of viral 56 expression following stimulation of chronically infected Jurkat cell lines and in vitro infection 57 models (1, 7). However, studies carefully evaluating the level of methylation in the 5'LTR of 58 First, we used real-time PCR, as described previously (3), to determine the frequency of 71 resting CD4 + T cells carrying HIV DNA in the study subjects. The median copy number of HIV 72 DNA was 1,166 (range 905-3,946) per 10 6 resting CD4 + T cells (Table 1) . 73 Next, we measured the level of DNA methylation within the HIV 5' LTR ( 2.5%, range 0-2.7%) to that of resting CD4 + T cells. To verify the ability of our methodology to 92 detect methylated CpG dinucleotides, we used DNA from previously described Jurkat cell lines, 93 H12 and 2D12, harboring differentially methylated HIV DNA (1). In accordance with previous 94 data (1), we could detect hypo-and hyper-methylated HIV 5' LTR, in H12 and 2D12 cell line, 95 respectively (Fig. 1C) . 96
In addition to the analysis of DNA methylation in the HIV 5' LTR, we examined HIV 97 envelope sequences (135 bp within the envelope coding region) comprising a CpG island (2) that 98 do not contribute to the regulation of viral transcription. We found 21-60% of methylated CpG 99 dinucleotides in HIV env from the resting CD4 + T cells of 4 study subjects (Fig. 1D ). These data 100 indicate that HIV DNA in resting CD4 + T cells of aviremic individuals is capable of being CpG 101
methylated. 102
In the present study, we have demonstrated very low levels of methylated CpG 
